Skip to content

Dogwood Therapeutics DWTX Other Research And Development Expense

Other Research And Development Expense at other companies

OS Therapies logo
OS TherapiesOSTX
$0
CTO
Citius Oncology, Inc.CTOR
$469K-2.3%
Celanese Corporation logo
Celanese CorporationCE
$0
Corvex
 logo
Corvex MOVE
$899K+12.4%
RFL
Rafael Holdings, Inc.RFL
$22K-51.1%
Comstock Inc. logo
Comstock Inc.LODE
$0-100%

Segments

By segment

See full
Single Reportable$585.61K+33.4%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×